Mirova Portfolio holdings
Mirova is a Paris-based asset manager devoted to sustainable investing and an affiliate of Natixis Investment Managers. Philippe Zaouati founded it in 2012 as a department of Natixis Asset Management (later renamed Ostrum Asset Management), and in 2014 it became a direct affiliate of Natixis Investment Managers. Mirova aims to build every portfolio to fit a climate path below 2°C, and its Althelia funds invest in the sustainable management of land and marine resources. It bought SunFunder, a Nairobi-based specialist in clean energy and climate investment in emerging markets, in 2022, and in 2020 became a mission-driven company under French law.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGCO
AGCO
|
+$2.2M |
| 2 |
Masco
MAS
|
+$2M |
| 3 |
CSX
CSX
|
+$1.72M |
| 4 |
HA Sustainable Infrastructure Capital
HASI
|
+$1.67M |
| 5 |
Eversource Energy
ES
|
+$1.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$5.7M |
| 2 |
Tesla
TSLA
|
+$5.15M |
| 3 |
Mastercard
MA
|
+$2.49M |
| 4 |
Array Technologies
ARRY
|
+$2.09M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.38% |
| 2 | Technology | 24.47% |
| 3 | Materials | 14.56% |
| 4 | Industrials | 8.82% |
| 5 | Financials | 5.69% |
Similar funds
Mirova's Q4 2022 Portfolio in Review
As of Q4 2022, Mirova held 200 positions worth $639M, up 7.5% from $594M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Mirova's Q4 2022 filing shows 29 new, 103 increased, 41 reduced and 19 closed positions. Its largest new stake was Masco: 41,474 shares worth $1.94M. The largest sale was Thermo Fisher Scientific, an estimated $5.7M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Materials.
- Mirova's largest Q4 2022 buy was Masco: 41,474 shares worth $1.94M.
- Mirova added most to AGCO in Q4 2022, an estimated $2.2M increase.
- Mirova's biggest Q4 2022 reduction was Thermo Fisher Scientific, cutting an estimated $5.7M.
- Mirova fully exited Tesla in Q4 2022, selling an estimated $5.15M.
- Mirova's ten largest holdings make up 58% of its $639M portfolio in Q4 2022.
- Mirova opened 29 new positions and closed 19 in Q4 2022.
- Mirova's portfolio value rose 7.5% quarter-over-quarter to $639M.
Based on Mirova's 13F filing for Q4 2022, filed 13 Feb 2023.